Forensic medicine and toxicology: drug addiction.
作者信息
Bewley T H
出版信息
Br Med J. 1967 Sep 2;3(5565):603-5. doi: 10.1136/bmj.3.5565.603.
Abstract
摘要
相似文献
1
Forensic medicine and toxicology: drug addiction.
Br Med J. 1967 Sep 2;3(5565):603-5. doi: 10.1136/bmj.3.5565.603.
2
[PROBLEMS IN FORENSIC TOXICOLOGY].
Dtsch Z Gesamte Gerichtl Med. 1965 Jun 8;56:125-42.
3
BARBITURATE POISONING.
N Engl J Med. 1965 Jul 1;273:38-9. doi: 10.1056/NEJM196507012730110.
4
[Continuous challenges in Japanese forensic toxicology practice: strategy to address specific goals].
Nihon Hoigaku Zasshi. 2002 Sep;56(2-3):219-28.
5
[From medicolegal toxicology to forensic toxicology].
Nihon Hoigaku Zasshi. 2000 Nov;54(3):330-44.
6
The Integration of Medical Toxicology and Addiction Medicine: a New Era in Patient Care.
J Med Toxicol. 2016 Mar;12(1):79-81. doi: 10.1007/s13181-015-0523-7.
7
Addiction Medicine: Current Status of Certification, Maintenance of Certification, Training, and Practice.
J Med Toxicol. 2016 Mar;12(1):76-8. doi: 10.1007/s13181-015-0524-6.
8
Applications of Metabolomics in Forensic Toxicology and Forensic Medicine.
Int J Mol Sci. 2021 Mar 16;22(6):3010. doi: 10.3390/ijms22063010.
9
Newspaper reports from the Coroners Court in Ireland are used to reveal the potential complexity and need for reform in forensic toxicology and medicine services.
J Forensic Leg Med. 2015 May;32:47-52. doi: 10.1016/j.jflm.2015.02.016. Epub 2015 Mar 5.
10
Progress in forensic toxicology: beyond analytical chemistry.
J Anal Toxicol. 1982 Mar-Apr;6(2):57-61. doi: 10.1093/jat/6.2.57.
引用本文的文献
1
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper.
Basic Clin Neurosci. 2020 Mar-Apr;11(2):133-150. doi: 10.32598/bcn.11.covid19.1. Epub 2020 Apr 12.
2
Excretion kinetics of urinary metabolites in a patient addicted to richloroethylene.
Br J Ind Med. 1971 Apr;28(2):203-6. doi: 10.1136/oem.28.2.203.
本文引用的文献
1
Persistent hypercalcemia associated with bronchogenic carcinoma and primary chiefcell hyperplasia of the parathyroids.
Am Rev Respir Dis. 1962 May;85:727-34. doi: 10.1164/arrd.1962.85.5.727.
2
Incidence of hypercalcemia in patients with proved carcinoma of the lung.
J Lancet. 1962 Apr;82:165-7.
3
Assessment of urinary phosphate excretion.
Lancet. 1960 Apr 30;1(7131):947-51. doi: 10.1016/s0140-6736(60)90836-9.
4
Acute hypercalcaemia from carcinomatosis without bone metastasis.
Br Med J. 1960 Apr 30;1(5182):1330-1. doi: 10.1136/bmj.1.5182.1330.
5
HYPERPARATHYROIDISM AND CANCER.
Br Med J. 1964 Jul 25;2(5403):218-21. doi: 10.1136/bmj.2.5403.214-a.
6
RENAL ADENOCARCINOMA CONTAINING A PARATHYROID HORMONE-LIKE SUBSTANCE AND ASSOCIATED WITH MARKED HYPERCALCEMIA.
Am J Med. 1964 May;36:805-14. doi: 10.1016/0002-9343(64)90188-3.
7
IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA.
J Exp Med. 1964 Mar 1;119(3):467-84. doi: 10.1084/jem.119.3.467.
8
PLASMA-CHLORIDE LEVELS IN HYPERPARATHYROIDISM AND OTHER HYPERCALCAEMIC STATES.
Br Med J. 1964 May 2;1(5391):1153-6. doi: 10.1136/bmj.1.5391.1153.
9
HYPERCALCAEMIA AND CANCER.
Postgrad Med J. 1963 Nov;39(457):646-9. doi: 10.1136/pgmj.39.457.646.
10
The separate effects of hyperparathyroidism, hypercalcemia of malignancy, renal failure, and acidosis on the state of calcium, phosphate, and other ions in plasma.
J Clin Invest. 1962 Jul;41(7):1454-71. doi: 10.1172/JCI104601.
Zotero 插件